Tissue | Expression Dynamics | Abbreviation |
Cervix | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Cervix/TNKS_pca_on_diff_genes.png) | CC: Cervix cancer |
HSIL_HPV: HPV-infected high-grade squamous intraepithelial lesions |
N_HPV: HPV-infected normal cervix |
Colorectum (GSE201348) | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Colorectum/Becker/TNKS_pca_on_diff_genes.png) | FAP: Familial adenomatous polyposis |
CRC: Colorectal cancer |
Colorectum (HTA11) | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Colorectum/Chen/TNKS_pca_on_diff_genes.png) | AD: Adenomas |
SER: Sessile serrated lesions |
MSI-H: Microsatellite-high colorectal cancer |
MSS: Microsatellite stable colorectal cancer |
Endometrium | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Endometrium/TNKS_pca_on_diff_genes.png) | AEH: Atypical endometrial hyperplasia |
EEC: Endometrioid Cancer |
Esophagus | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Esophagus/TNKS_pca_on_diff_genes.png) | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias |
LGIN: Low-grade intraepithelial neoplasias |
Liver | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Liver/TNKS_pca_on_diff_genes.png) | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
Lung | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Lung/TNKS_pca_on_diff_genes.png) | AAH: Atypical adenomatous hyperplasia |
AIS: Adenocarcinoma in situ |
IAC: Invasive lung adenocarcinoma |
MIA: Minimally invasive adenocarcinoma |
Prostate | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Prostate/TNKS_pca_on_diff_genes.png) | BPH: Benign Prostatic Hyperplasia |
Thyroid | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Thyroid/TNKS_pca_on_diff_genes.png) | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis |
PTC: Papillary thyroid cancer |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00519734 | Colorectum | CRC | positive regulation of telomerase activity | 12/2078 | 34/18723 | 1.78e-04 | 3.17e-03 | 12 |
GO:20012525 | Colorectum | CRC | positive regulation of chromosome organization | 21/2078 | 82/18723 | 1.82e-04 | 3.20e-03 | 21 |
GO:00182103 | Colorectum | CRC | peptidyl-threonine modification | 28/2078 | 125/18723 | 2.10e-04 | 3.55e-03 | 28 |
GO:00070633 | Colorectum | CRC | regulation of sister chromatid cohesion | 9/2078 | 21/18723 | 2.12e-04 | 3.56e-03 | 9 |
GO:20005735 | Colorectum | CRC | positive regulation of DNA biosynthetic process | 18/2078 | 66/18723 | 2.21e-04 | 3.69e-03 | 18 |
GO:00330443 | Colorectum | CRC | regulation of chromosome organization | 37/2078 | 187/18723 | 3.34e-04 | 5.10e-03 | 37 |
GO:00902633 | Colorectum | CRC | positive regulation of canonical Wnt signaling pathway | 24/2078 | 106/18723 | 4.89e-04 | 7.00e-03 | 24 |
GO:00070623 | Colorectum | CRC | sister chromatid cohesion | 16/2078 | 62/18723 | 9.40e-04 | 1.15e-02 | 16 |
GO:00322045 | Colorectum | CRC | regulation of telomere maintenance | 19/2078 | 80/18723 | 9.89e-04 | 1.18e-02 | 19 |
GO:00007235 | Colorectum | CRC | telomere maintenance | 26/2078 | 131/18723 | 2.29e-03 | 2.20e-02 | 26 |
GO:00070643 | Colorectum | CRC | mitotic sister chromatid cohesion | 9/2078 | 28/18723 | 2.43e-03 | 2.30e-02 | 9 |
GO:00070044 | Colorectum | CRC | telomere maintenance via telomerase | 16/2078 | 69/18723 | 3.12e-03 | 2.75e-02 | 16 |
GO:00511003 | Colorectum | CRC | negative regulation of binding | 30/2078 | 162/18723 | 3.36e-03 | 2.87e-02 | 30 |
GO:00322065 | Colorectum | CRC | positive regulation of telomere maintenance | 13/2078 | 52/18723 | 3.71e-03 | 3.12e-02 | 13 |
GO:00322102 | Colorectum | CRC | regulation of telomere maintenance via telomerase | 13/2078 | 53/18723 | 4.42e-03 | 3.47e-02 | 13 |
GO:00064035 | Colorectum | CRC | RNA localization | 35/2078 | 201/18723 | 4.64e-03 | 3.61e-02 | 35 |
GO:19043585 | Colorectum | CRC | positive regulation of telomere maintenance via telomere lengthening | 10/2078 | 37/18723 | 5.78e-03 | 4.31e-02 | 10 |
GO:19043565 | Colorectum | CRC | regulation of telomere maintenance via telomere lengthening | 14/2078 | 61/18723 | 6.06e-03 | 4.46e-02 | 14 |
GO:00070513 | Colorectum | CRC | spindle organization | 32/2078 | 184/18723 | 6.70e-03 | 4.77e-02 | 32 |
GO:0034086 | Colorectum | CRC | maintenance of sister chromatid cohesion | 5/2078 | 12/18723 | 6.79e-03 | 4.77e-02 | 5 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TNKS | SNV | Missense_Mutation | novel | c.401C>T | p.Ser134Phe | p.S134F | O95271 | protein_coding | deleterious_low_confidence(0.01) | benign(0.248) | TCGA-A2-A0CR-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | CR |
TNKS | SNV | Missense_Mutation | rs767692118 | c.3854N>G | p.Asn1285Ser | p.N1285S | O95271 | protein_coding | deleterious(0.02) | benign(0.198) | TCGA-A2-A4S2-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | CR |
TNKS | SNV | Missense_Mutation | rs762904486 | c.286N>G | p.Ile96Val | p.I96V | O95271 | protein_coding | deleterious_low_confidence(0.04) | benign(0) | TCGA-D8-A145-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | tamoxiphen | SD |
TNKS | insertion | Frame_Shift_Ins | novel | c.560_561insTTGTTGTTTTTGTGACAGGGTCTCC | p.Glu188CysfsTer62 | p.E188Cfs*62 | O95271 | protein_coding | | | TCGA-AN-A0FN-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TNKS | deletion | Frame_Shift_Del | novel | c.3731delT | p.Ile1244AsnfsTer11 | p.I1244Nfs*11 | O95271 | protein_coding | | | TCGA-EW-A2FV-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | docetaxel | SD |
TNKS | SNV | Missense_Mutation | rs753349258 | c.932N>A | p.Arg311Gln | p.R311Q | O95271 | protein_coding | tolerated(0.08) | benign(0.036) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
TNKS | SNV | Missense_Mutation | novel | c.2087N>A | p.Arg696His | p.R696H | O95271 | protein_coding | tolerated(0.27) | probably_damaging(0.985) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
TNKS | SNV | Missense_Mutation | novel | c.3482N>A | p.Arg1161Gln | p.R1161Q | O95271 | protein_coding | deleterious(0) | probably_damaging(0.976) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
TNKS | SNV | Missense_Mutation | | c.1240N>T | p.His414Tyr | p.H414Y | O95271 | protein_coding | deleterious(0.01) | probably_damaging(0.997) | TCGA-C5-A1BF-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | PD |
TNKS | SNV | Missense_Mutation | rs372614885 | c.3978N>C | p.Lys1326Asn | p.K1326N | O95271 | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.966) | TCGA-C5-A7UI-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |